⚠️ Federal Law: Schedule I — All Quantities
Under 21 U.S.C. § 812, psilocybin (and psilocin) are Schedule I controlled substances. There is no legal threshold — a 0.1g microdose carries the same federal classification as 10 grams. Federal prosecution of individual microdosers is extremely rare in practice, but the legal risk is real. State laws create practical protections but do not override federal law.
Jurisdiction-by-Jurisdiction Breakdown
MOST PERMISSIVE
🟢 Colorado
Proposition 122 (2022) allows adults 21+ to possess, use, and gift (not sell) psilocybin mushrooms. Licensed "healing centers" are operational as of 2024. Personal home use and microdosing carry no state criminal penalty. Best practical legal protection for microdosers in the US.
CIVIL INFRACTION
🟡 Oregon
Measure 110 (2020) decriminalized personal possession of all drugs to civil fines ($100). Measure 109 created the licensed psilocybin service framework. Home microdosing is a low-priority civil infraction, not a crime. Licensed session centers provide legal supervised use.
DECRIMINALIZED
🟡 California
SB 58 (2023) decriminalized personal possession and use of psilocybin mushrooms for adults. No criminal penalty at state level for small quantities. Sale and distribution remain illegal. No licensed service centers yet — regulatory framework delayed to 2026-2027.
FULLY ILLEGAL
🔴 All Other States
47 states maintain full Schedule I classification for psilocybin. Some cities within these states have passed non-enforcement resolutions (see below), but state law controls. Possession carries criminal penalties ranging from misdemeanor to felony depending on quantity and state.
Federal vs. State Law Comparison
| Jurisdiction |
Status |
Possession Penalty |
Applicable Since |
| Federal (DEA) |
Schedule I |
Up to 1yr / $1,000 (simple possession) |
1971 — Controlled Substances Act |
| Colorado |
Decriminalized / Legal possession |
None for personal amounts (21+) |
June 2023 — Prop 122 |
| Oregon |
Civil infraction only |
$100 civil fine (non-criminal) |
February 2021 — M110 + M109 |
| California |
Decriminalized (personal use) |
None for personal amounts (SB 58) |
January 2024 — SB 58 |
| Most other states |
Class A/B misdemeanor or felony |
Fine to 1-5yr imprisonment |
1970s state analog acts |
Decriminalized Cities — Non-Enforcement Zones
These cities have passed resolutions directing police to deprioritize enforcement of psilocybin possession. These are not laws and don't protect against state or federal prosecution, but they create practical low-risk environments.
Denver, CO 2019
Oakland, CA 2019
Santa Cruz, CA 2020
Ann Arbor, MI 2020
Washington DC 2020
Somerville, MA 2021
Cambridge, MA 2021
Northampton, MA 2021
Seattle, WA 2021
Detroit, MI 2021
San Francisco, CA 2022
Berkeley, CA 2022
Arcata, CA 2022
Minneapolis, MN 2022
Hazel Park, MI 2022
Ferndale, MI 2022
Easthampton, MA 2022
Amherst, MA 2023
Portland, ME 2023
Missoula, MT 2023
What Is Microdosing? Science and Protocols
A microdose is typically 1/10th to 1/20th of a full psychedelic dose — sub-perceptual, meaning it doesn't cause hallucinations or significant alteration of consciousness. The research suggests potential benefits for treatment-resistant depression, anxiety, ADHD, and creative cognition, though placebo-controlled trials show mixed results.
🗓️ Fadiman Protocol
Day 1: Dose · Day 2: Afterglow · Day 3: Rest · Repeat
Developed by psychedelic researcher James Fadiman. One of the most widely studied microdosing schedules. Allows for a "rest day" to prevent tolerance buildup. Standard dose: 0.1–0.3g dried mushrooms.
🍄 Stamets Protocol
5 days ON · 2 days OFF
Developed by mycologist Paul Stamets. Often combined with Lion's Mane mushroom and niacin. Higher frequency than Fadiman. Claims neurogenesis synergy with the mushroom stack. Some report stronger cumulative effects.
🔬 Every Other Day
Alternating: Dose · Rest · Dose · Rest
Simpler to maintain than Fadiman protocol. Used in several research trials. Allows for cleaner comparison days. Standard dose: 0.05–0.2g. Preferred in some clinical research contexts for consistency.
📋 Intuitive / As-Needed
Based on subjective need — no fixed schedule
Many experienced practitioners microdose based on intuition rather than fixed protocols. Used by some with depression or ADHD who dose on challenging days only. Less studied but widely practiced in self-medication contexts.
OOTWOracle Predictions: Microdosing Legalization Timeline
OOTWOracle's 8 specialized AI agents analyze regulatory signals daily. Here's the current consensus on microdosing-related milestones:
Federal rescheduling (Schedule I → III/IV)
12%
by Jan 2028
5th state decriminalizes psilocybin
61%
by Jan 2028
FDA approves psilocybin drug (COMP360/Usona)
52%
by Jan 2028
NY or WA state decriminalization
41%
by Jan 2027
50+ US cities with non-enforcement
73%
by Jan 2028
Microdosing explicitly addressed in federal law
8%
by Jan 2028
Oracle Agent Views on Microdosing Policy
🏛️ FDA Regulatory Reviewer
FDA approval of a psilocybin drug wouldn't automatically legalize microdosing — that's a different regulatory track. But it would trigger a required DEA scheduling review within 90 days and create enormous political pressure to revisit Schedule I status entirely.
🚔 DEA Intelligence Officer
DEA has zero enforcement appetite for individual microdosers. Resources go to trafficking. The political risk of prosecuting a depressed professional for 0.1g mushrooms is massive. Schedule I status serves as a legal backstop but practical enforcement is near-zero for personal amounts.
🔬 MAPS Researcher
The microdosing research landscape is exploding — 40+ active clinical trials examining sub-perceptual psilocybin. Imperial College, UCSF, and Johns Hopkins all have active programs. Positive Phase 3 data on depression could accelerate rescheduling discussions significantly.
💊 Neuropharmacologist
The pharmacological argument for Schedule I (no accepted medical use) is collapsing. Oregon has accepted medical use. Australia has accepted medical use. FDA has granted Breakthrough Therapy designations to two psilocybin drugs. Schedule III or IV is scientifically more defensible now.
🎖️ Veteran Advocate
Veteran microdosing for PTSD and TBI is happening at scale regardless of legality. VA can't prescribe it but won't discharge for it. The political optics of prosecuting veterans for mushrooms are catastrophic. This community is a key driver of state-level decriminalization momentum.
📰 Investigative Journalist
Silicon Valley normalized microdosing for 15 years before any legislation. The practice is completely mainstream now — NYT, WSJ, and Bloomberg have all run positive feature coverage. That cultural normalization is the leading indicator that legislative change follows, typically 3-5 years behind.
Frequently Asked Questions
Is microdosing psilocybin illegal federally? +
Yes. Psilocybin is Schedule I under the federal Controlled Substances Act regardless of quantity. Simple possession is up to 1 year imprisonment. In practice, federal prosecution of individual microdosers is nearly unheard of — but the legal risk technically exists under federal law.
Can I microdose legally in Colorado or California? +
Colorado: Yes, adults 21+ can legally possess psilocybin mushrooms under Prop 122 — no state criminal penalty. California: SB 58 decriminalized personal use and possession for adults — no state criminal penalty. In both states, federal law technically still applies but DEA virtually never prosecutes personal-amount users in decriminalized state contexts.
What's the difference between decriminalization and legalization? +
Decriminalization removes criminal penalties (jail time) but the substance may still be technically illegal, with civil fines possible. Legalization fully permits possession, use, and typically commercial sale with regulation. Oregon and Colorado have effectively legalized personal use; most other "decriminalized" cities have only passed non-enforcement resolutions with no legal force.
Will FDA approval of psilocybin therapy make microdosing legal? +
Not automatically. FDA approval of a psilocybin drug (like COMP360) would create a Schedule II or III prescription drug for that specific compound. It would trigger a required DEA scheduling review that could reduce overall psilocybin restrictions — but wouldn't automatically permit personal microdosing without a prescription. The political pressure on Congress to act would be enormous, however.
Is it safe to microdose psilocybin? +
Psilocybin has very low toxicity and no known lethal dose in humans. Microdosing at sub-perceptual levels (0.05-0.3g) carries minimal acute physiological risk. Potential concerns include: amplifying underlying anxiety or mood disorders in some individuals, drug interactions (especially SSRIs — blunting effect, serotonin syndrome risk), and impaired judgment in rare cases. Consultation with a mental health professional is strongly advised.
How many Americans microdose? +
Survey research suggests 5-8% of US adults have tried psilocybin microdosing at least once, with approximately 2-3 million regular practitioners. This has grown substantially since 2018. The practice is highest among tech workers, creative professionals, and veterans — three demographics with significant political voice, which helps explain rapid legislative progress.
🔮 Track Microdosing Legalization in Real Time
OOTWOracle's 8-agent AI system monitors FDA signals, DEA notices, congressional bills, and state legislation daily — updating probability scores every 24 hours.
View Today's Oracle Report →
Related Research